The effect of fluoxetine on covid-19

The association between fluoxetine and level of ESR , CRP in patients with covid-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220404054411N1

Enrollment

Registered

2023-01-14

Start date

2022-05-22

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 disease. U07.1 COVID-19, virus identified

Interventions

Intervention 1: Intervention group: Fluoxetine 20 mg , Selective serotonin reuptake inhibitor , The patient takes 20 mg of fluoxetine daily from the time of admission , We continue the medicine until

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Definitive diagnose of covid 19 Have a written consent

Exclusion criteria

Exclusion criteria: Liver and kidney failure Taking drug that interfere with fluoxetine

Design outcomes

Primary

Measure	Time frame
Determining the effect of fluoxetine on the red blood cell sedimentation rate in patients with COVID-19 infection. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Blood level measurement by laboratory.;Determining the effect of fluoxetine on the C-reactive protein in patients with COVID-19 infection. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Blood level measurement by laboratory.	—

Measure

Time frame

Determining the effect of fluoxetine on the red blood cell sedimentation rate in patients with COVID-19 infection. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Blood level measurement by laboratory.;Determining the effect of fluoxetine on the C-reactive protein in patients with COVID-19 infection. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Blood level measurement by laboratory.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKimia Sobouti Moghadam

Semnan University of Medical Sciences

Kimia.moghadam9675@gmail.com+98 23 3344 3147

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026